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Abstract
Entry into mitosis is triggered by activation of Cdk1 and inactivation of its counteracting phosphatase PP2A/B55. Greatwall
kinase inactivates PP2A/B55 via its substrates Ensa and ARPP19. Both Greatwall and Ensa/ARPP19 are regulated by
phosphorylation, but the dynamic regulation of Greatwall activity and the phosphatases that control Greatwall kinase and
its substrates are poorly understood. To address these questions we applied a combination of mathematical modelling and
experiments using phospho-specific antibodies to monitor Greatwall, Ensa/ARPP19 and Cdk substrate phosphorylation
during mitotic entry and exit. We demonstrate that PP2A/B55 is required for Gwl dephosphorylation at the essential Cdk site
Thr194. Ensa/ARPP19 dephosphorylation is mediated by the RNA Polymerase II carboxy terminal domain phosphatase Fcp1.
Surprisingly, inhibition or depletion of neither Fcp1 nor PP2A appears to block dephosphorylation of the bulk of mitotic
Cdk1 substrates during mitotic exit. Taken together our results suggest a hierarchy of phosphatases coordinating Greatwall,
Ensa/ARPP19 and Cdk substrate dephosphorylation during mitotic exit.
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Introduction
Phosphorylation of more than thousand proteins by Cdk1 and
other mitotic kinases drives entry into mitosis [1,2]. As cells exit
mitosis, these post-translational modifications have to be removed
by phosphatases. Mitotic kinase and phosphatase activity appears
to be inversely regulated to avoid futile cycles of phosphorylation
and dephosphorylation [3,4]. Moreover, mitotic kinases them-
selves are regulated by phosphorylation and dephosphorylation
resulting in a complex feedback system of cell cycle control [5].
Cdk1 is negatively regulated by phosphorylation at Thr14/Tyr15
by Wee1 and Myt1 kinases and dephosphorylation of this site by
the Cdc25 phosphatase constitutes the decision point to enter
mitosis [6]. Cdk1 actively participates in its own activation by
negatively regulating its inhibitor Wee1 [7–9] and positively
regulating its activator Cdc25 [10]. In Xenopus egg extracts this
switch is counteracted by the phosphatase PP2A/B55d [11,12]
suggesting that inhibition of PP2A/B55d is an intrinsic element of
the G2/M transition. This is achieved by Greatwall kinase (Gwl)
[13–15] that phosphorylates and activates the PP2A/B55d
inhibitors Endosulfin (Ensa) and ARPP19 [16–19]. The Gwl
phosphorylation motive FDSGDY is identical in Ensa and
ARPP19 and thus detectable with the same phospho-specific
antibody. For simplicity we will refer in our analysis to Ensa/
ARPP19, because it is impossible to distinguish between the
phosphorylation of the two proteins with specific antibodies.
Depletion of Gwl kinase in Xenopus mitotic extracts results in
rapid Cdk1 inactivation and exit from mitosis, while Gwl depletion
in interphase extracts blocks Cdk1 Thr14/Tyr15 dephosphoryla-
tion and mitotic entry [14,15]. In human cells Gwl kinase
depletion causes a delay in mitotic entry, reduces Cdk substrate
phosphorylation and results in chromosome alignment defects and
aberrant mitotic exit [20,21]. Cdk1 phosphorylates Gwl at
multiple sites and is required for its activation [22]. Thus, Cdk1
and Gwl activation are locked in a complex feedback loop at the
G2/M transition.
To gain a more precise understanding of this switch-like
transition, the phosphatases that target Gwl itself and Ensa/
ARPP19 have to be identified. Inactivation of these phosphatases
is likely to play a major role in the initiation of the Cdk1 activation
loop. Moreover, the reactivation of these phosphatases is likely to
be a crucial element during mitotic exit. The identity of the major
Cdk1 counteracting phosphatase in mammalian cells is also still
under debate. Current models propose that PP2A/B55d is not
only required for the Cdk1 activation loop, but also to directly
dephosphorylate mitotic substrates during mitotic exit [3,23].
Thus, PP2A/B55d has been proposed to be the major Cdk1
counteracting phosphatase during mitotic exit in Xenopus egg
extracts, equivalent to the function of Cdc14 phosphatase in
budding yeast. This hypothesis is based on the observation that
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co-depletion of Wee1, Myt1 and Gwl causes mitotic exit from
Xenopus egg extracts despite persistent high Cdk1 activity [24].
Conversely, B55d depletion does not block Cdk1 substrate
dephosphorylation, when mitotic exit is triggered by Cdk1
inhibition in Xenopus egg extracts [12] and PP1 has also been
implicated to act as a major mitotic exit phosphatase [25]. In
human cells PP2A/B55a has been implicated in regulating mitotic
exit, but B55a depletion shows only a delay but not a block of Cdk
substrate dephosphorylation following Cdk inactivation [26].
Thus, the network of phosphatases that counteract Gwl, Ensa/
ARPP19 and Cdk phosphorylation during mitotic exit remains to
be determined.
Results
1) Modelling Gwl and Cdk1 phosphorylation dynamics at
the G2/M transition and mitotic exit
To gain insight into the dynamics of the Gwl/Cdk1 feedback
loop during mitotic entry and exit we performed mathematical
modelling (see Material and Methods) of the Cdk1 regulatory
network shown on Fig. 1A. This network has multiple positive
circuits (positive and double-negative feedback loops) including the
antagonism between Cdk1 and PP2A/B55 that plays a key role in
the switch-like transitions at G2/M and mitotic exit. PP2A/B55
inhibits Cdk1 through the Tyr-modifying enzymes while Cdk1
down-regulates PP2A/B55 activity through Gwl and Ensa/
ARPP19 activation. As a consequence of these feedback loops
the network has two qualitatively different states corresponding to
G2 and M phases. In G2, both Gwl and Cdk1 are inactive while
PP2A/B55 is active, but in M phase the opposite is true. Based on
this information, we built mathematical models to analyse the
impact of different Gwl phosphatases on the dynamics of mitotic
entry and exit (Fig. S1). Inactivation of Cdk1 (by chemical
inhibition) stabilizes the G2 phase (high Cdk1 Tyr15 phosphor-
ylation, inactive Gwl and active PP2A/B55), allowing Cyclin B to
accumulate above the threshold normally required for G2/M
transition. Mitotic entry can be triggered by either terminating
Cdk1 kinase inhibition, or by inactivation of PP2A by Okadaic
acid (OA). In this scenario Cdk1 re-activation destabilizes the G2
state and initiates rapid transition into M phase characterized by
Tyr15 dephosphorylation, Gwl activation and PP2A/B55 inhibi-
tion (Fig. 1B–D). Conversely, PP2A inhibition causes only a slow
decrease in Cdk1 Tyr15 phosphorylation because phosphorylation
of Tyr-modifying enzymes is compromised by low Cdk1 activity
(Fig. 1E–G). If the Gwl phosphatase is insensitive to OA, PP2A
inhibition should not induce phosphorylation of these proteins,
because Cdk1 activity remains low and the counteracting
phosphatases are active (Fig. 1E). In contrast, if Gwl is targeted
by an OA sensitive phosphatase, Cdk1 Tyr-dephosphorylation
should be accompanied by Gwl phosphorylation (Fig. 1F and G).
For simplicity we presume constitutive activity of the Ensa/
ARPP19 phosphatase. Activation of Gwl overcomes this activity
and results in Ser67 phosphorylation. Furthermore, the model
predicts that Gwl phosphorylation precedes Tyr15-dephosphory-
lation (Fig. 1F and G) because the latter requires prior
phosphorylation of Cdc25 and Wee1 to remove the inhibitory
Tyr15 phosphorylation. To obtain further information about Gwl
phosphatases we also simulated mitotic exit triggered by Cdk1
inactivation (Fig. 1). The model suggests that Gwl will be
instantaneously dephosphorylated after Cdk1 inactivation, if a
constitutive phosphatase is responsible for its inactivation (Fig. 1H
and I). If the Gwl phosphatase is directly participating in a double
negative feedback loop (such as the M-phase inactive phosphatase
PP2A/B55) then Gwl inactivation is a slow process to allow for
time of phosphatase reactivation (Fig. 1J). Thus, our model of the
kinetics of mitotic entry and exit potentially revealed important
information about the nature of the Gwl phosphatase, which can
be tested experimentally.
2) Detecting an essential Cdk site in the putative T-loop
of Gwl kinase
To test these predictions it is necessary to monitor Gwl
phosphorylation during mitotic entry and exit using a phospho-
specific antibody. In order to study potential Gwl activation by
phosphorylation, we scanned for Cdk consensus sites following the
universal DFG motif in Gwl that marks the beginning of the T-
loop/activation segment. Fig. 2A shows that there is a conserved
Threonine (Thr194 in human Gwl) followed by a Proline about 20
residues downstream of the DFG motif. When mutated to Alanine,
only Thr194, but not Thr193 results in a significant loss of Gwl
activity (Fig. 2B and C) whereas a Thr194Ser mutation does not
affect Gwl kinase activity (Fig. S2A). The equivalent of human Gwl
Thr194 in Xenopus is also required for kinase activity and mutants
lacking this phosphorylation site are unable to reconstitute Gwl
depleted egg extracts, suggesting that phosphorylation of this
residue is essential for survival [22]. We therefore raised a
phospho-specific pThr194 antibody to monitor Gwl phosphory-
lation at this residue. Fig. 2D shows that the antibody detects Flag-
Gwl immuno-precipitated from nocodazole-arrested cells. We
detected only weak signal in Gwl purified from asynchronous, and
no signal in Gwl from Cdk1 inhibited cells, and also in a mitotic
Thr194Ala mutant of Gwl. The antibody also detected Gwl
specifically in mitotically enriched cells following a double
Thymidine block release synchronisation (Fig. 2E and Fig. S2B).
To determine, if Thr194 was directly phosphorylated by Cdk, we
incubated WT and Thr194Ala Flag-Gwl that was immuno-
precipitated from asynchronous human cells with recombinant
cycA/Cdk2 in the presence of ATP (Fig. 2F). Addition of
recombinant CycA/Cdk2 resulted in strong Thr194 phosphory-
lation. Applying alkaline phosphatase to the reaction significantly
reduced the signal and the Thr194Ala mutant did not cross-react
with the phospho-specific antibody after incubation with cycA/
Cdk2. These data demonstrate that Thr194 is a Cdk site that is
phosphorylated during mitosis in human cells and that the Gwl
pThr194 antibody specifically cross-reacts with this phosphorylat-
ed residue.
We also determined the precise localization and timing of Gwl
Thr194 phosphorylation by immunofluorescence (Fig. S2C–D).
The pThr194 antibody strongly stained mitotically arrested cells
and this signal was absent in most mitotic cells after Gwl siRNA
depletion (Fig. S2C). There was little background signal detectable
Author Summary
Greatwall kinase regulates a switch between kinase and
phosphatase activity during mitotic entry and constitutes
an essential element of mitotic control. This control system
is further complicated by the fact that Greatwall itself is
regulated via phosphorylation and acts by phosphorylat-
ing its substrates ENSA and ARPP19. A missing link in this
central mitotic switch is the phosphatase that counteracts
Greatwall and its target Ensa. We have used mathematical
modeling and experimental validation to identify these
phosphatases. We demonstrate genetic evidence that
Greatwall phosphorylation is counteracted by PP2A/B55,
while Fcp1 regulates ENSA dephosphorylation. Based on
these findings we present a new model for the regulation
of mammalian cell division.
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in interphase cells, but Gwl Thr194 phosphorylation occurred in
the nucleus of G2 cells with separated centrosomes, increased in
metaphase cells on the mitotic spindle and decreased to
background levels in telophase cells (Fig. S2D). In prophase cells
Gwl Thr194 phosphorylation occurred both in the nucleus and at
the centrosomes (Fig. 2G). Mitotic Gwl was specifically enriched at
the spindle poles and also showed distinctive foci in the metaphase
plate that overlap with CenpA, suggestive of centromeric
localization (Fig. 2H). This centromeric and polar phosphorylation
was absent in early anaphase cells, while cytoplasmic Gwl
Figure 1. The regulatory network and the dynamics of the mitotic switch. (A) Model of the Cdk1 activation switch. Cdk1 activity is regulated
by inhibitory Tyr15 phosphorylation modulated through the activities of Wee1 and Cdc25. The activity of these modifying enzymes are regulated
both directly and indirectly (through Gwl, Ensa/ARPP19 and PP2A/B55) by Cdk1. (B–J) Simulation of mitotic entry and exit using a mathematical
model of the regulatory network with the assumption included that Gwl is dephosphorylated by an OA-insensitive phosphatase (left panels), by an
OA-sensitive phosphatase (middle panels), or specifically by PP2A/B55 (right panels). The simulation of mitotic entry is shown from the initial
condition obtained using Cdk1 inhibition and either removal of Cdk1 inhibition (B–D) or PP2A inhibition by OA (E–G) promotes mitotic entry. The
mitotic exit (H–J) is shown from the initial condition corresponding to metaphase state and Cdk1 inhibition promotes mitotic exit.
doi:10.1371/journal.pgen.1004004.g001
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appeared to remain phosphorylated, indicating a localised
phosphatase activation in the early anaphase spindle.
3) Gwl Thr194 but not Ensa/ARPP19 is regulated by an
OA sensitive phosphatase
The availability of antibodies to monitor Cdk, Gwl and Ensa/
ARPP19 phosphorylation allowed us to experimentally test the
mathematical models described in Fig. 1. This required a system to
specifically inactivate and rapidly re-activate Cdk1. For this
purpose we used the previously published cdk1as DT40 cell-line
[27]. These chicken lymphocytes have the advantage of a rapid
and complete re-activation of Cdk1 following removal of the ATP
analogue inhibitor 1NMPP1. Thr194 was not phosphorylated in
1NMPP1 inhibited cdk1as cells, suggesting that in vivo Cdk1 is
required for this phosphorylation. Release from Cdk1 inhibition
by 1NMPP1 resulted in rapid simultaneous Cdk1 Tyr15 de-
phosphorylation and Gwl Thr194 phosphorylation within 5 min-
utes (Fig. 3A and B). As predicted by the models presented in
Fig. 1E–G, treatment of the 1NMPP1 inhibited cells with OA
triggered a much slower G2/M switch and caused Cdk1 Tyr15
dephosphorylation after 60 minutes of phosphatase inhibition and
a steady increase in Cdk substrate phosphorylation (Fig. 3C and
D). Gwl Thr194 and Ensa/ARPP19 phosphorylation occurred
rapidly within 30 minutes of OA addition (Fig. 3C and D). These
data correlate with the models in Fig. 1F and G demonstrating
that Gwl phosphatase is OA sensitive. The experiments also verify
the prediction that Gwl phosphorylation precedes Cdk1 dephos-
phorylation.
Figure 2. Gwl Thr194 is an essential Cdk1 phosphorylation site. (A) Multiple amino-acid sequence alignment of Gwl sequence following the
DFG motif. (B) IP/kinase assay of transiently expressed Flag-tagged WT and T193A/Thr194A mutant Gwl from nocodazole arrested HEK 293T cells
using MBP as a substrate. (TCE total cell extract, IP immuno-precipitate) (C) Quantification of kinase assays as shown in (B). The average of 3
independent experiments was calculated and the error bars show the standard deviation between the different assays. (D) IP/Western of transiently
expressed Flag WT and Thr194A mutant Gwl from asynchronous, RO3306, or nocodazole arrested HEK 293T cells. (E) Immunoblot of HeLa cell extracts
following a double thymidine release sampled at indicated time points. Cell cycle progression was simultaneously monitored by PI staining and FACS
analysis (see Fig. S2B). The cells passed through mitosis between 8 and 10 hours following release as indicated. (F) Gwl phosphorylation by CycA/
Cdk2 in vitro. Flag WT and Thr194A Gwl was transiently expressed and purified from asynchronous HEK 293T cells and incubated with recombinant
CycA/Cdk2, following treatment with alkaline phosphatase (aPh) in the indicated samples. The proteins were analysed by immuno-blotting with anti-
Gwl and Gwl pThr194 antibodies. (G) Centrosome staining of Thr194 phosphorylated Gwl in prophase cells using co-localisation with c-tubulin as a
centrosomal marker. (H) Differential Thr194 phosphorylation of Gwl at spindle poles and centromeres in metaphase and anaphase cells. CenpA
staining was used as a centromeric marker. Deconvolved maximum intensity projections are shown.
doi:10.1371/journal.pgen.1004004.g002
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Our model was built on the assumption that Ensa/ARPP19 is
targeted by a constitutive phosphatase. Therefore, PP2A inhibition
induced Gwl activation should result in a steady increase of
phosphorylation of Ensa/ARPP19. However, Ensa/ARPP19
phosphorylation initially increased at 30 and 60 minutes after
OA, but was lost at the 120 minutes timepoint, when Cdk1 was
fully dephosphorylated (Fig. 3D). This prompted us to hypothesize
that perhaps another OA insensitive phosphatase is activated at
this late time point that can target Ensa/ARPP19, but not Gwl
Thr194 phosphorylation. To test, if this activity was sensitive to
other phosphatase inhibitors we repeated the experiment in the
presence of the PP1 inhibitor tautomycin (TC). Fig. 3D (OA+TC)
shows that this alternative inhibitor is indeed sufficient to suppress
Ensa/ARPP19 dephosphorylation at the 120 minute timepoint.
These data suggest that Gwl Thr194 phosphorylation is opposed
by an OA sensitive phosphatase and that this phosphorylation
occurs before Tyr15 dephosphorylation. Our data also suggest that
Ensa/ARPP19 phosphorylation is targeted by a different phospha-
tase that is sensitive to TC, or a combination of OA and TC.
4) Dephosphorylation dynamics during mitotic exit
To gain further insight into the dephosphorylation dynamics of
Gwl-Ensa/ARPP19 and Cdk substrates, we experimentally tested
the mitotic exit models in Fig. 1H–J. For this purpose we arrested
cells in mitosis and then triggered mitotic exit by Cdk1 inhibition.
The effects of Cdk inhibitors on metaphase arrested cells are
somewhat contentious [28–30]. To try and address this problem,
we performed the mitotic exit experiment with three different
Cdk inhibitors in the presence of proteasome inhibition and OA
(Fig. S3A and S3B). Cdk substrate dephosphorylation was
triggered by Roscovitine, Flavopiridol and RO3306 and
progressed with comparable dynamics in the presence of
proteasome and PP2A inhibition. However, OA appeared to
cause an increase in Cdk phosphorylation activity in the
metaphase arrested cells suggesting a role of OA sensitive
phosphatases such as PP2A on Cdk substrate phosphorylation
at this cell cycle stage. The effect of the Cdk inhibitors was not a
result of off-target effects on Gwl, because none of the
compounds affected Gwl in vitro activity (Fig. S3C).
Figure 3. Testing Gwl and Ensa/ARPP19 phosphorylation in the G2/M switch. (A) Experimental protocol: DT40 cdk1as cells are blocked in
G2 phase by 1NMPP1. Mitosis is triggered either by removing 1NMPP1 from the media, or by treating the cells with 1 mM OA. (B) Immuno-
fluorescence analysis of cdk1as cells before (0) and 5 minutes after (5) release from G2 by 1NMPP1 removal using DAPI and the indicated antibodies.
(C) Immuno-fluorescence analysis of mitotic entry in 1NMPP1 arrested cdk1as cells at indicated timepoints after treatment with 1 mM OA. (D)
Immuno-blot analysis of 1NMPP1 treated cdk1as cell extracts taken at indicated timepoints following OA treatment, or from cells treated with both
1 mM OA and 10 mM TC.
doi:10.1371/journal.pgen.1004004.g003
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For the purpose of testing the model, we chose the Cdk1
inhibitor RO3306. We blocked cells in mitosis using the Eg5
inhibitor STLC, and triggered mitotic exit by Cdk1 inhibition with
RO3306. Our model predicts that Cdk1 inactivation is sufficient
to trigger mitotic exit and that Gwl and Ensa/ARPP19
dephosphorylation would progress slowly, if the counteracting
phosphatase is locked in a double negative feedback loop with
Gwl, which is indeed what was observed. Gwl, Ensa/ARPP19 and
Cdk substrate dephosphorylation all occur with a 15–30 minutes
delay (Fig. 4A left most panel). We then tested the sensitivity of
these dephosphorylation events to OA and TC. In accordance
with our results presented in Fig. 3C & D, this experiment
suggests that Gwl Thr194 dephosphorylation is OA sensitive,
while Ensa/ARPP19 dephosphorylation is only inhibited in the
presence of both OA and TC that inhibit both PP2A and PP1
(Fig. 4A). Accordingly, a higher dose OA concentration of 5 mM
can also inhibit Ensa dephoshorylation (Fig. S3D). Both OA and
TC did cause an increase in Cdk phosphorylation in the mitotic
cells. However, Cdk substrate dephosphorylation did appear to
proceed with unperturbed dynamics in the OA+TC treated cells
following Cdk1 inhibition and was only blocked in the presence
of a more global phosphatase inhibitor Calyculin A (CalA)
(Fig. 4E).
We also observed that Gwl still shifts towards lower electro-
phoretic mobility, suggesting additional dephosphorylation of
other residues, despite the presence of OA and TC and the block
in Thr194 dephosphorylation (Fig. 4A). This suggests that other
phosphatases may also contribute to Gwl dephosphorylation at
residues different from Thr194. This notion prompted us to
analyse the effect of phosphatase inhibitors on Gwl activity. For
this purpose we expressed Flag-Gwl in HeLa cells synchronised in
mitosis by STLC, and measured the in vitro kinase activity of
immuno-precipitated Gwl before and after Cdk1 inhibition in the
presence of different phosphatase inhibitors. Cdk1 inactivation
caused a reduction to 10% of mitotic Gwl activity as well as
Thr194 dephosphorylation and disappearance of the Gwl band-
shifts (Fig. 4C and D). After OA addition, Gwl Thr194
dephosphorylation remained unchanged, and the protein re-
mained active to a level of 60% relative to the mitotic control.
Surprisingly, addition of TC caused a small increase in Thr194
dephosphorylation, but did not significantly affect Gwl activity. In
both cases (OA and OA+TC) the high bandshift Gwl bands, were
only gradually shifted down compared to the untreated control.
Calyculin A led to a much more significant change in
electrophoretic mobility of Gwl and blocked the inactivation of
Gwl following Cdk1 inhibition to give about 80% activity,
relative to the mitotic control. This suggests that Thr194
phosphorylation, as well as the bulk activity of Gwl, is
counteracted by an OA sensitive phosphatase. However, other
phosphorylation events in the protein are controlled by OA
resistant phosphatases that have an additional but smaller impact
on kinase activity.
5) Differential requirement for PP2A/B55 and Fcp1 to
dephosphorylate Gwl and Ensa/ARPP19
PP2A/B55 itself is a good candidate for the Gwl Thr194
phosphatase, but the experiments with OA do not allow
discriminating between different PP2A complexes and other OA
sensitive phosphatases. This is suggested by the slow dephosphor-
ylation following Cdk1 inactivation (Fig. 4A) fitting to a model of
Figure 4. Characterizing Gwl, Ensa/ARPP19 and SP dephosphorylation during mitotic exit. (A) HeLa cells were synchronized in mitosis by
Eg5 inhibition using 5 mM STLC and pretreated for one hour with 1 mM OA, 10 mM TC or both. Samples were taken for extraction and immunoblot
analysis at indicated timepoints following treatment with 10 mM RO3306. (B) Quantification of relative Cdk substrate (phospho-SP)
dephosphorylation in OA and TC treated cells. Error bars indicate standard deviation calculated from three independent experiments. (C)
Immunoblot analysis of STLC arrested cells following one hour treatment with 100 nM Calyculin A (CalA). Extracts were taken at indicated times after
Cdk1 inhibition by 10 mM RO3306. (D) MBP Kinase assays with immuno-precipitated Flag-Gwl that was transiently expressed in HeLa cells. Flag-Gwl
was purified from STLC arrested cells before and 30 minutes after RO3306 treatment. Cells were pretreated for one hour with the indicated
phosphatase inhibitors. (E) Quantification of MBP kinase activity following Cdk1 inhibition (+RO) relative to mitotic cells before Cdk1 inhibition (-RO).
Error bars indicate the standard deviation calculated from three independent experiments.
doi:10.1371/journal.pgen.1004004.g004
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double negative feedback between Gwl and the Gwl phosphatase
(Fig. 1J). To test this hypothesis we performed siRNA depletion of
B55a and d subunits and monitored Gwl dephosphorylation
following Cdk1 inactivation of STLC synchronized mitotic cells
(Fig. 5A). Depletion of B55a and d had a synergistic effect and
significantly blocked Gwl Thr194 dephosphorylation. This dem-
onstrates that both PP2A/B55a and d contribute to this event.
Similar to the OA experiments B55a and d depletion did cause an
increase in metaphase Cdk substrate phosphorylation but did not
affect the relative amount of Cdk1 substrate dephosphorylation
following Cdk1 inhibition.
The results presented in Fig. 3 and 4 demonstrate that the
identity of the Ensa/ARPP19 phosphatase is different from the
ones targeting Gwl and other Cdk substrates. However, these data
do not allow us to conclude on the nature of this phosphatase other
than its sensitivity to a combination of OA and TC. The RNA
polymerase II C-terminal tail domain phosphatase Fcp1 has
recently been shown to play an important role during mitotic exit
[31,32]. We hypothesised that Fcp1 may be required for Ensa/
ARPP19 dephosphorylation and tested this idea using Fcp1
siRNA. Fig. 5B shows that depletion of Fcp1 had no effect on Gwl
Thr194 and Cdk substrate dephosphorylation following Cdk1
inactivation, but blocked dephosphorylation of Ser67 in Ensa/
ARPP19.
To confirm that PP2A/B55 and Fcp1 can directly dephosphor-
ylate Gwl and Ensa, we set up in vitro phosphatase assays using
recombinant substrates [12] (see Materials and Methods). We
purified transiently expressed Flag-B55a and GFP-Fcp1 from
nocodazole treated mitotic Hek293T cells before or after Cdk1
inhibition by Flag and GFP immuno-precipitation (Fig. 5C and
D). In the case of Gwl we observed a significant increase in
phosphatase activity with B55a purified from mitotic cells before,
or after Cdk1 inhibition (Fig. 5C). This could mean that PP2A/
B55 is already active in a mitotic arrest, or that we activated it
during the purification process. GFP-Fcp1, on the other hand,
appeared to dephosphorylate Ensa only when purified from
mitotic extracts after Cdk1 inhibition (Fig. 5D), suggesting a more
stable (potentially post-translational) regulation of this phosphatase
during mitotic exit. We also tested the sensitivity profile of Fcp1
against phosphatase inhibitors to determine whether OA and TC
synergistically inactivate it, as suggested by the results in Fig. 4A. In
vitro, both 1 mM OA and 10 mM TC were sufficient to inhibit this
Ensa phosphatase (Figure S3E). It is difficult to relate the in vitro
and in vivo concentrations of the phosphatase inhibitors, because of
transport into and out of the cell and competitive binding between
different phosphatases. Most likely, the combination of OA and
TC has a synergistic effect in inhibiting Fcp1, but we cannot rule
out indirect effects from inhibition of other phosphatases by
combining OA and TC.
Discussion
The results presented here suggest a complex phosphatase
network counteracting the Cdk1 activation loop. These data allow
us to update the model of the mammalian mitotic switch by
including the new information on PP2A/B55 and Fcp1 (Fig. 6).
The inclusion of an additional layer of phosphatase regulation
does not alter the fundamental characteristic of the mitotic switch
model, but it influences the temporal dynamics of mitotic entry
and exit. Our mathematical modeling together with experiments
indicates that mutual antagonism between Gwl and PP2A/B55
accelerates both mitotic entry and exit with synthesis and
degradation of CycB, respectively. Our data also indicate that
while PP2A is principally responsible for the inactivation step of
Gwl, phosphatases other than PP2A regulate additional phos-
phorylation sites and also contribute to Gwl inactivation (see
Fig. 4C and D). We have also identified Fcp1 as the phosphatase
counteracting the Gwl phosphorylation site in Ensa/ARPP19.
This implicates that Fcp1 is yet another intrinsic element of the
mitotic switch and helps explain the observation that this
phosphatase is required for mitotic exit [32]. Fcp1 appears to be
subjected to further regulation by Cdk1 and activated during
mitotic exit. These novel elements of the mitotic switch remain to
be investigated.
Strikingly neither PP2A, PP1 nor Fcp1 appear to be sufficient to
dephosphorylate the bulk of mitotic Cdk1 substrates, if the Gwl
feedback loop is bypassed by Cdk1 inhibition. Dephosphorylation
of the majority of Cdk substrates proceeds despite the presence of
inhibitors (Fig. 4A), depletion of B55 subunits (Fig. 5A) and Fcp1
(Fig. 5B) and persistent activation of Gwl and Ensa (Fig. 4A and
5B), which additionally inhibit PP2A/B55. These results suggest
that PP2A/B55 is not the only mitotic exit phosphatase that
removes the bulk of mitotic phosphorylation. This notion is also
supported by experiments in Xenopus egg extracts, in which Cdk1
inhibition by p27 can trigger mitotic dephosphorylation even in
the absence of B55d [12]. This is further supported by the
observation that B55 depleted cells do not show a prolonged arrest
in mitosis, as would be expected in the absence of the major Cdk1
antagonizing phosphatase [26]. Thus, the nature of the phospha-
tases that directly counteracts Cdk1 during the mitotic exit in
mammalian cells remains elusive. In yeast Cdc14 covers this role,
but single deletions of the mammalian equivalents Cdc14 A and B
do not have the expected mitotic phenotypes [33,34]. However, a
double deletion of both orthologues has, to our knowledge, not
been reported. Further experiments will be necessary to identify
the mammalian version of this crucial mitotic exit phosphatase,
and to analyse how it is integrated in the mitotic entry and exit
switches.
Materials and Methods
Entry into mitosis is triggered by the activation of Cdk1/CycB.
The network that controls Cdk1/CycB activity involves regulation
of inhibitory kinase, Wee1 and activatory phosphatase, Cdc25. In
interphase, Wee1 dependent phosphorylation keeps Cdk1 inactive
while Cdc25 dependent dephosphorylation activates Cdk1 and
promotes entry into mitosis. Both Wee1 and Cdc25 are subjected
to Cdk1/CycB dependent phosphorylations which lead to the
inactivation of Wee1 and activation of Cdc25. As a consequence,
Cdk1 activity is controlled by feedback loops involving Wee1
(Cdk1—|Wee1—|Cdk1) and Cdc25 (Cdk1RCdc25RCdk1).
Cdk1 subunit is in excess compared to its activating partner
Cyclin B. Therefore, it is assumed that all Cyclin B is in the
complex such that total CyclinB (CycBT) is sum of active Cdk1/
CycB and inactive Cdk1/CycB dimers.
The network also includes the regulation of Cdk1/CycB
counteracting phosphatase, PP2A/B55. We consider that the
dephosphorylation of Wee1 and Cdc25 is controlled by PP2A/
B55. Cdk1 indirectly inhibits PP2A/B55 via Gwl-Ensa/ARPP19
pathway. Thus, Cdk1 promote Wee1 and Cdc25 phosphorylations
by directly phosphorylating them and by indirectly inhibiting their
phosphatase forming coherent feed-forward loops. Gwl-Ensa/
ARPP19 pathway involves Cdk1/CycB dependent phosphoryla-
tion of Gwl (Gwl) which in turn phosphorylate the phosphatase
inhibitor Ensa/ARPP19. The phosphorylated Ensa/ARPP19
binds directly to PP2A/B55 to form an inhibitory complex. The
phosphatases that dephosphorylate Gwl and Ensa/ARPP19 are
unknown. Therefore, we consider three different scenarios. Gwl is
PP2A/B55 and Fcp1 Regulate Greatwall and Ensa
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dephosphorylated by (A) OA insensitive phosphatase (B) OA
sensitive phosphatase (PP2A) and (c) PP2A/B55. We also assume
that ENSAPt (sum of phosphorylated forms of Ensa/ARPP19) is
dephosphoryated by OA insensitive phosphatase. We predict using
the model the effect of different phosphatases on both the steady
state of the system and dynamics of chemical inhibitor induced
mitotic entry and exit.
The temporal dynamics of each component in the network is
described by non-linear ordinary differential equation (ODE). All
the individual biochemical reactions are approximated by mass
action kinetics. The set of ODEs are integrated numerically using
stiff solver in XPPAUT, a freely available program from G. Bard
Ermentrout, University of Pittsburgh, PA, USA; http://www.
math.pitt.edu/,bard/xpp/xpponw95.html).
One parameter bifurcation diagrams (Suppl. Fig. S1) were
computed using the program AUTO. Bifurcation diagram is
used to illustrate how steady state of the dynamical system
changes as a function of control parameter. We compute the
diagram with respect to CycBT as a parameter since its level is
unaffected by the dynamics of the system. We present the
XPPAUT code of model that can be used to re-produce all the
simulations (Fig. 1 and Fig. S1) in the manuscript. The
comparative analysis of the three models is carried out by
using the same set of parameter values except for the changes
corresponding to Gwl phosphatase (see below). The total
concentrations of the proteins are assumed to be equal to one
except for PP2A (PP2t = 0.5) whose concentration is kept below
its stoichiometric inhibitor, ENSA concentration. The choice of
Figure 5. Identifying the phosphatases required for Gwl and Ensa/ARPP19. (A) Dephosphorylation of Gwl and SP sites in B55 depleted cells.
HeLa cells were transfected with combinations of B55a and d siRNAs and synchronized in mitosis with STLC as above (see Materials & Methods). Cell
extracts were sampled before and 30 minutes after RO3306 treatment and analyzed by immuno-blotting with indicated antibodies. (B)
Dephosphorylation of Gwl, Ensa/Arpp19 and SP sites in Fcp1 depleted cells. HeLa cells were transfected with Fcp1 siRNA and synchronized in mitosis
with STLC (see Materials & Methods). Cell extracts were sampled before and 30 minutes after RO3306 treatment and analyzed by immune-blotting
with indicated antibodies. (C) Gwl phosphatase assay with immuno-precipitated Flag-B55a. Purified his-Gwl was phosphorylated by Cdk2/cycA and
c32P ATP. Cdk2/cycA was removed from the reaction by further purification with Ni-Agarose beads and radiolabeled phospho-Gwl was incubated
with immunoprecipitated B55a. The presence of the PP2A/B55a complex in the immune-precipitate was confirmed by immuno-blotting.
Phosphatase activity was measured by scintillation counting of released [32]P phosphate. (D) Similar phosphatase assay as in (C) with recombinant in
vitro phosphorylated Ensa and immuno-precipitated GFP-Fcp1.
doi:10.1371/journal.pgen.1004004.g005
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kinetic parameter values is based on the criteria that G2/M
transition should exhibit bistable characteristic [4][6]. Two
parameter bifurcation diagrams were used to study the
dependence of bistability on kinetic parameter values. We
observed bistable behaviour over a wide range of kinetic
parameters values (kagwl.1; kigwl9=0–10; kaensa.1;
kiensa = 0–2.5) and within this range the dynamical character-
istics of the three models as shown in Figure 1B–J are not
affected. These characteristics include rapid Tyr15 dephosphor-
ylation (in all the three models) during mitotic entry with Cdk1
inhibition and release in comparison with the Cdk1 inhibition +
OA and delay in Gwl inactivation during mitotic exit only when
Gwl is dephosphorylated by PP2A/B55. The inclusion of
PP2A/B55 dependent regulation of Gwl also makes the system
bistable over wider range of total Cyclin B levels, because of
extra double–negative feedback loop between Gwl and PP2A/
B55.
The parameter values in XPPAUT code correspond to the
situation of Gwl dephosphorylation by PP2A/B55 and the other
two models can be simulated with following changes: Gwl
dephosphorylation by OA insensitive phosphatase: kigwl9=2;
kigwl = 0.
Gwl dephosphorylation by OA sensitive phosphatase (PP2A):
kigwl0=2; kigwl = 0.
The chemical inhibition of Cdk1 and PP2A are modelled as a
reversible inhibitor binding reaction. The mitotic entry simulation
in the presence of inhibitor is done with parameter value RO=25
(for Cdk1 inhibition), OA=100 (for PP2A inhibition).The mitotic
exit simulation in the presence of inhibitor is done with parameter
value RO=100 (for Cdk1 inhibition).
XPPAUT file containing ODEs, parameter values and
initial conditions
# Initial conditions
init MPF= 0, Cdc25= 0, Wee1= 1, Gwl = 0, ENSAPt= 0,
PP2= 0.5
# Use the following initial conditions for mitotic exit
# MPF=0.96, Cdc25= 0.97, Wee1= 0.03, Gwl = 0.9, EN-
SAPt = 0.75, PP2= 0.027
#Differential equations
MPF9=k25*(CycT-MPF) - kwee*MPF
Cdc259=Va25*MPFa*(Cdc25T-Cdc25) - Vi25*PP2a*Cdc25
Wee19=Vawee*PP2a*(Wee1T-Wee1) - Viwee*MPFa*Wee1
Gwl9=kagwl*MPFa*(GwlT-Gwl) - (kigwl9+ kigwl0*PP2T/(1+OA)
+ kigwl*PP2a)*Gwl
ENSAPt9=kaensa*Gwl*(ENSAT - ENSAPt) - kiensa*ENSAPt
PP29= -kas*(ENSAPt - (PP2T-PP2))*PP2 + (kdis + kiensa)*(PP2T
-PP2)
MPFa=MPF/(1+RO)
PP2a=PP2/(1+OA)
Figure 6. Revised model of the Cdk1 activation loop. The regulation of Gwl dephosphorylation by PP2A/B55 and Ensa/ARPP19
dephosphorylation by Fcp1 are incorporated into the previous network shown on Fig. 1A. Since Fcp1 is inhibited in Cdk1 dependent manner, Ensa is
regulated by a coherent feed-forward loop as well: Cdk1 both activates the phosphorylation (via Gwl) and inhibits the dephosphorylation (via Fcp1)
of Ensa.
doi:10.1371/journal.pgen.1004004.g006
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aux preMPF=CycT-MPF
aux PP2a=PP2/(1+OA)
aux MPFa=MPF/(1+RO)
k25= k259*(Cdc25T-Cdc25) + k250*Cdc25
kwee = kwee9*(Wee1T -Wee1) + kwee0*Wee1
#parameters
par CycT=1, Va25=2, Vi25= 2, Vawee= 2, Viwee = 2
par kagwl = 10, kigwl9=0.02, kigwl0=0, kigwl = 2, kaensa = 2,
kiensa = 0.6
par kas = 100, kdis = 1
par Cdc25T=1, Wee1T=1, GwlT= 1, ENSAT=1,
PP2T=0.5,
par k259=0.01, k250=1, kwee9=0.01, kwee0=1
par RO=0, OA=0
@ total = 30,dt = 0.5,meth= STIFF
@ xlo= 0,xhi = 30,ylo = 0,yhi = 1
@ NPLOT=6, yp1= preMPF, yp2=Cdc25, yp3=ENSAPt,
yp4 =PP2a, yp5=Gwl
@ NTST=15,NMAX=20000,NPR=1000,DS= 0.02
@ DSMAX=0.05,DSMIN=0.001,PARMIN= -1,PARMAX=1
@ AUTOXMIN = 0,AUTOXMAX = 1,AUTOYMIN = 0,
AUTOYMAX=1
done
Cloning and mutagenesis
Gwl cDNA was cloned by RT-PCR from mRNA isolated from
HeLa cells using RNeasy mini kit (Quiagen). Reverse-transcriptase
PCRs (RT PCRs) were performed using the SuperScript III One-
Step RT-PCR System from Invitrogen. Gwl cDNA was amplified
from HeLa cell messenger RNA (mRNA) (using primers 59GGG
GAC AAG TTT GTA CAA AAA AGC AGG CTT AAT GGA
TCC CAC CGC GGG AAG c39; 59GGG GAC CAC TTT GTA
CAA GAA AGC TGG GTC CTA CAG ACT AAA TCC AGA
TAC GG39) and cloned into the pCR II-TOPO cloning vector
using the TOPO-TA Cloning Kit from Invitrogen. In all cases the
manufacturer’s recommended protocols were followed and the
presence of the expected DNA sequences confirmed by restriction
digestion and sequencing. The cDNA was then cloned into an N-
terminal Flag tag mammalian expression destination vector (a gift
from Dr. Stephan Geley, University of Innsbruck, Austria). Site
directed mutagenesis was carried out using the QuickChange XL
Site-Directed Mutagenesis Kit from Stratagene (California, USA)
following the manufacturer’s protocol. Human B55a was cloned
by RT-PCR as above using the primers 59GGG GAC AAG TTT
GTA CAA AAA AGC AGG CTT A ATG GCA GGA GCT
GGA GGA GG39 and 59GGG GAC CAC TTT GTA CAA GAA
AGC TGG GTC CTA ATT CAC TTT GTC TTG AA39 cloned
into a Gateway Flag-tag expression vector. Fcp1 cDNA was
synthesized by Genscript and cloned into the EGFP-C1 vector via
Bgl2 and EcoR1 sites. Human Ensa was cloned by RT-PCR using
the primers 59 GGG G ACA AGT TTG TAC AAA AAA GCA
GGC TTA ATG TCC CAG AAA CAA GAA GA 39 and 59
GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC TCA
TTC AAC TTG GCC ACC CG39 and further cloned into a
his-tag Gateway bacterial expression vector (a gift from Dr.
Stephan Geley, University of Innsbruck, Austria).
Antibodies
Rabbit phospho-(Ser) CDKs substrate antibody was pur-
chased from Cell Signaling. Peptides and polyclonal rabbit
Phospho-Thr194 Gwl were generated and purified by Eurogentec,
Belgium. Peptides and polyclonal rabbit phospho-Ser67 Ensa/
ARPP19 was generated by Generon and we also obtained a
phosphor-specific P-Ser67 Ensa antibody from Dr. Satoru
Mochida (Kumamoto University, Japan). To make phospho-
specific monoclonal antibody (mAB) to phospho threonine and
tyrosine on cdk1, a phospho-peptide EKIGEGpTpYGVVYKGC
was coupled to KLH and injected into Balb/c mice. Hybridoma
cells produced from the spleen cells from a hyperimmune mouse
were fused with Sp/0 myeloma cells using standard procedures.
Positive clones were identified using immunoadsorbent assays and
immunoblotting of Xenopus egg extracts. mAb CP3.2 gave the
strongest signal in these assays.; a -tubulin (clone DM1A), myc
(clone 9E10) and CENPA (clone 3–19) mouse monoclonal
antibodies were purchased from Abcam (Cambridge, UK),
PP2A/B55a (clone 2G9) and PP2A/B55 (clone D-10) mouse
monoclonal antibodies from Santa Cruz Biotechnology (Heidel-
berg, Germany),PP2AC from Sigma (SAB4200266), histone H3
mouse monoclonal antibody (clone 6.6.2) from Millipore (Watford,
UK) and mouse monoclonal anti-MASTL from Sigma
(HPA027175). HRP-conjugated and polyclonal goat anti-rabbit
or mouse antibodies were from Dakocytomation (UK). Secondary
antibodies for immunofluorescence were from Invitrogen.
Cell culture
HeLa cells were cultured in Dulbecco’s modified Eagle Medium
(DMEM) supplemented with 10% FBS, 2 mM L-glutamine,
100 U/mL penicillin and 0.1 mg/mL streptomycin in a 37uC,
5% CO2 incubator. Chicken DT40 cells including cdk1as cells
were cultured as previously described (24).
G2/M transition experiments
Cdk1as cells were synchronized in G2 with 10 mM 1NMPP1 for
6 h, then were released in mitosis after 1NMPP1 wash out and
collected 5 min later for immunofluorescence assays. Alternatively,
G2 cells were incubated with 1 mM of OA or/and 10 mM TC for
indicated times and harvested for immuno-fluorescence and
immuno-blotting analysis.
Mitotic exit experiments
HeLa cells were synchronized with 5 mM of S-trityl-L-cysteine
(STLC; Tocris, Bristol, UK) for ,18 h, then were harvested by
mitotic shake-off. The cells were then incubated in STLC-
containing media supplemented with 1 mM of okadaic acid (OA;
Calbiochem, Merck Chemicals, Nottingham, UK) or/and 10 mM
of tautomycetin (TC; Tocris), or 100 nM of calyculin A
(Calbiochem) for 1 h. Next, Cdk1 activity was inhibited with
10 mM of RO3306 (Calbiochem) for 0, 15 or 30 min and the cells
were collected for immunoblotting analysis.
To knock-down PP2A/B55a and d subunits, 40 nM of each
siRNA B55 (59-GCAGAUGAUUUGCGGAUUA-39 for B55a
and 59-CAUCCAUAUCCGAUGUAAA-39 for B55d, Qiagen,
Manchester, UK) were reverse transfected using Lipofectamine
RNAiMAX reagent (Invitrogen) two consecutive days according
to the provider’s instructions. The cells were treated with STLC
for mitotic synchronization 48 h after the 2nd transfection and
mitotic exit experiment was carried out the following day.
Immunoblotting
Cells were lysed in 40 mL of EBC buffer (50 mM Tris pH 7.5,
120 mM NaCl, 0.5% NP40, 1 mM EDTA, 1 mM DTT, Protease
and Phosphatase inhibitors (Complete and PhosStop; Roche
Diagnostics, West Sussex, U.K)) and 10 ml 56 sample buffer
(0.01% bromophenol blue, 62.5 mM Tris-HCl pH 6.8, 7% SDS,
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20% sucrose and 5% b-mercaptoethanol). The samples were
sonicated then boiled at 95uC for 5 min. Samples were then
analysed by western blotting and the signal was using Immobilon
Western Chemiluminescent HRP substrate (Millipore). Image J
was used to quantify the intensity of phospho-(Ser) CDKs substrate
signal. a-tubulin was used to normalize the samples.
Immuno-precipitation and kinase assay
HeLa cells were transfected with 10 mg of Flag-Gwl plasmid
(using GeneJuice transfection reagent (Novagen, Merck Chemi-
cals) following the manufacture’s guidelines. Hek293T cells were
transfected using CaCl2. 24 h later, 5 mM of STLC, 75 ng/mL
Nocodazole or 10 mM RO3306 was added to the media and
incubated for 16–18 h. Indicated cells were then treated with
1 mM of OA or/and 10 mM of TC or 100 nM of calyculin A for
1 h. Mitotic exit was induced by adding 10 mM of RO3306 for
30 min. Cells were lysed on ice for 20 min in IP buffer (20 mM
TrisHCl ph 7.5, 137 mM NaCl, 10% glycerol, 0.5% NP-40,
2 mM EDTA, Protease and Phosphatase inhibitors (Complete and
PhosStop)) supplemented with the appropriate phosphatase
inhibitors (OA and/or TC or Calyculin A). Protein samples were
clarified by centrifugation at 13 000 rpm for 30 min at 4uC. Flag-
Gwl protein was captured on anti-flag M2 magnetic beads (Sigma)
for at least 2 h at 4uC. After 2 washes with IP buffer and 2 with
kinase buffer (50 mM MOPS pH 7.5, 5 mM MgCl2, 0.4 mM
EDTA and 0.4 mM EGTA), the beads were incubated with 10 mg
of myelin basic protein (MBP, Millipore) diluted in kinase buffer
supplemented with 25 mM of ATP and 0.003 MBq of c-32P-ATP
for 20 min at 37uC. The reaction was stopped by adding the
sample buffer and was analysed by western blot and autoradiog-
raphy. Recombinant Cdk2/cycA was a gift from Dr. Julian
Gannon (CRUK Clare Hall, UK).
Immuno-fluorescence
HeLa cells were grown on coverslip, then were fixed with 3.7%
of formaldehyde (Sigma-Aldrich, Dorset, UK) in PBS for 10 min
(Fig. 2B) or mitotic cells were collected and were spun onto slides
at 500 r.p.m. for 5 min then fixed (Fig. 2C). DT-40 cells were
cyotspun at 1000 r.p.m. for 3 min then fixed. After several PBS
washes, cells were permeabilized with 0.1% NP-40 in PBS fro 10–
20 min then stained with indicated antibodies and mounted with
Prolong Gold DAPI solution (Invitrogen, Paisley, UK).
Images were acquired on DeltaVision microscope equipped
with a UPLS Apo, N.A. 1.40, 1006 oil immersion objective
(Olympus), standard filter sets (Excitation 360/40; 490/20; 555/
28; Emission 457/50; 528/38; 617/40) and a CoolSNAP_HQ2
camera (Photometrics). Images were exported to Omero software
(Version 4.4.4). Deconvolution were performed using SVI
Huygens Professional Deconvolution Software (Version 3.5) and
images were converted into Adobe Photoshop files.
Phosphatase assay
Recombinant His-tagged Ensa was purified using Ni-NTA
agarose (Qiagen) from BL21 E.coli following the manufacturer’s
protocol. 1 mg of purified protein was then phosphorylated for 2 h
at 37uC by recombinant engineered Gwl kinase (Hochegger lab,
unpublished results) in kinase buffer (20 mM Hepes-HCl pH 7.8,
10 mM MgCl2, 15 mM KCl, 1 mM EGTA, 5 mM NaF, 20 mM
b-glycerophosphate, 1 mM DTT and 1.85 MBq c-32P-ATP
(PerkinElmer)). To eliminate unincorporated ATP and the kinase,
the phosphor-Ensa protein was captured on Ni-NTA beads. After
elution, the phospho substrate was concentrated by spinning on
ultrafiltration columns (Vivaspin 500, 3 000 MWCO, Fisher) in
buffer containing 20 mM TrisHCl pH 7.5, 150 mM NaCl and
0.01% Tween 20. Hek293 cells were transfected with GFP-FCP1
using a calcium phosphate transfection protocol. 24 h later, cells
were treated with 100 ng/mL of nocodazole for 16–18 h and
mitotic cells were incubated in DMSO or 10 mM of RO3306 for
30 min at 37uC. GFP-FCP1 was then immunoprecipitated from
cell extracts using magnetic GFP-Trap_M beads (Chromotek,
Germany) according to the provider’s instructions. After washes,
beads were resuspended in phosphatase buffer (20 mM Hepes-
NaOH pH 7.9, 10 mM MgCl2, 20 mM KCl, 10% glycerol,
1 mM DTT and, 0.2 mM PMSF). Phospho-Ensa was added to
the mixture and samples were incubated for 90 min at 30uC. The
reaction was stopped by TCA protein precipitation then the
samples were treated as described in [12]. The radioactivity was
measured with a liquid-scintillation counter.
Recombinant His-tagged Gwl was produced in insect cells and
purified on Ni-Agarose beads. and concentrated by spinning on
ultrafiltration columns (Vivaspin 2, 10 000 MWCO) in 40%
glycerol/PBS buffer. His-tagged Gwl was phosphorylated in vitro
by the recombinant Cdk2/cyclinA complex (a gift from Tim
Hunt). The kinase reaction and the purification of the phosphor-
ylated substrate were similar to the preparation of the phosphor-
ylated recombinant ENSA. Flag-B55a was transfected in HEK293
cells. The phosphatase assay with B55a was carried out in a similar
way as FCP1 phosphatase assay except the Flag-B55a was
captured on anti-flag M2 magnetic beads (Sigma) and phosphor-
ylated his-Gwl was used as a substrate.
Supporting Information
Figure S1 Steady state analysis of the mitotic switch. The steady
state fraction of Tyr15 Cdk1 phosphorylation and phosphorylated
Gwl are plotted as a function of CycB levels, assuming that Gwl is
dephosphorylated by an OA-insensitive (A), an OA-sensitive
phosphatase (B) or by PP2A/B55 (C). The ‘balance curves’ were
calculated in the absence of any inhibitor (green curves), in the
presence of Cdk1 inhibitor (red curves) and Cdk1 plus PP2A
inhibitors (blue curves). Solid and dashed lines represent stable and
unstable steady states, respectively. Down-regulation of the
phosphatase on Wee1 and Cdc25 by Cdk1 activity is required
to generate bistability in our model. This is achieved through the
Cdk1-dependent activation of the Gwl-ENSA pathway that
inhibits PP2A:B55 phosphatase. This explains the loss and the
persistence of bistability after Cdk1 and PP2A combined inhibition
(blue curves) with OA-insensitive (Fig. S1A) and OA-sensitive (Fig.
S1B and S1C) Gwl phosphatase, respectively. An OA-insensitive
phosphatase keeps Gwl unphosphorylated at low Cdk1 activity
therefore PP2A:B55 activity becomes independent of Cdk1
activity. However, if Gwl is dephosphorylated by an OA-sensitive
phosphatase (e.g. PP2A:B55 or any other PP2A), Gwl phosphor-
ylation and thereby PP2A:B55 activity is still Cdk1 dependent,
assuming not a complete inhibition by OA.
(TIF)
Figure S2 (A) WT and Thr194Ser Flag-Gwl were transiently
expressed in 293T cells. 48 hours after transfection the cells were
synchronized in mitosis by 18 hour incubation with nocodazole.
Mutant and WT kinase were immuno-precipitated and assayed for
kinase activity using MBP as a substrate. The kinase assays were
analyzed by SDS PAGE and autoradiography. (B) FACS profile of
thymidine release samples taken at indicated time points after
thymidine washout. Cells passed through mitosis between 8 hours
and 10 hours, correlating with Gwl Thr194 phosphorylation. (C)
siRNA depletion of Gwl to determine specificity of the immuno-
fluorescent signal of the phosphor Thr194 antibody. Cells were
siRNA transfected with control and Gwl siRNA. 48 hours later,
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cells were treated with STLC to achieve mitotic arrest and stained
with anti Gwl pThr194 (green), anti-atubulin (red) and DAPI
(blue). Note the mitotic cells that lost Gwl Thr194 signal in the
knock-down sample. (D) Analysis of Gwl Thr194 phosphorylation
by immunofluorescence with anti-Gwl pThr194 antibodies. DAPI
staining and centrosome separation was used to identify mitotic
cells at various stages.
(TIF)
Figure S3 Mitotic exit triggered by Cdk inhibition. (A) Cells
were arrested in mitosis by STLC and pretreated with 1 mM OA
and 20 mM MG132 before inactivation of Cdk1 by 50 mM
Roscovitine (Ros), 5 mM Flavopiridaol (Fp) and 10 mM RO3306
(RO). Mitotic exit was scored by measuring levels of phosphor-
ylated SP by immune-blots. (B) Three independent experiments as
shown in (A) were quantified using Image J. Error bars indicate
standard deviation in the 3 data sets. (C) Effect of Cdk inhibitors
on Gwl activity measured by IP/kinase assays. Flag-Gwl was
transfected in 293T cells. 48 hours after transfection the cells were
arrested in nocodazole for 18 hours. Flag-Gwl was immuno-
precipitated from mitotic cells and incubated with recombinant
Ensa/ARPP19 and c32P ATP. The kinase assays were analyzed by
SDS PAGE and autoradiography. (D) Effects of 1 and 5 mM OA
on mitotic exit dephosphorylation. HeLa cells were synchronized
in mitosis by Eg5 inhibition using 5 mM STLC and pretreated for
one hour with 1 mM and 5 mM OA. Samples were taken for
extraction and immunoblot analysis at indicated timepoints
following treatment with 10 mM RO3306. (E) Effects of OA and
TC on FCP1 phosphatase activity. Ensa phosphatase were
performed as described in Figure 5 and the reactions were
incubated with 1 mM OA, 10 mM TC and 100 nM CalA.
(TIF)
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